Delivery Order SPE2DR25D7064-SPE2DR26F2NBH
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Thrombin-JMI 20,000 unit vials valued at $1,550.51. This firm fixed-price delivery order, with an ultimate completion date of October 31, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Thrombin-JMI 5,000 Units Vials with a ceiling value of $1,451.48. This firm fixed price delivery order, which represents a child contract under a larger indefinite delivery vehicle, will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility and is scheduled for completion by November 28, 2025. The award was not designated as a set-aside contract,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,150.20 for 5,000 units of Thrombin-JMI vials on December 30, 2025, with completion scheduled for December 31, 2025. This firm fixed-price contract, which was competitively awarded without a set-aside designation, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Thrombin is a critical hemostatic agent used in surgical and medical applications to control...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Thrombin-JMI 5,000 Units Vials on April 23, 2025, with a ceiling value of $1,334.80. This competitively awarded, firm fixed price delivery order is scheduled for completion by April 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract involves no set-aside designation, reflecting AmerisourceBergen's capability to compete in open...
- The Defense Logistics Agency awarded a delivery order valued at $1,009.40 to AmerisourceBergen Drug Corp for Thrombin USP Bovine on December 12, 2025, with an ultimate completion date of December 15, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Thrombin-JMI 20,000 Units Pumps on December 1, 2025, with a ceiling value of $1,488.35 and an ultimate completion date of December 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a relatively small-value transaction within the broader...
- The Defense Logistics Agency awarded a $1,789.73 delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical applications. This firm fixed-price delivery order, issued on December 31, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was competitively awarded with no...
- The Defense Logistics Agency awarded a delivery order valued at $2,746.32 to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical applications. This competitively awarded, firm fixed-price delivery order was issued on December 19, 2025, with an ultimate completion date of December 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at approximately $81,912 to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical applications. This firm fixed-price, non-set-aside contract was awarded on November 20, 2025, with an ultimate completion date of November 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child...
- This delivery order, awarded May 12, 2025, obligates $8,481.60 to AmerisourceBergen Drug Corp for the supply of 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical applications. The award is non-competitive and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. Performance will be completed by May 13, 2025, at the...
- SPE2DR25D7064Indefinite Delivery Contract
- SPE2DR25D7064-SPE2DR26F2NBHDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,150.20 to AmerisourceBergen Drug Corp for 5,000 units of Thrombin-JMI vials. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on December 30, 2025, with an ultimate completion date of December 31, 2025. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. That prime contract vehicle supports comprehensive global pharmaceutical supply for military healthcare programs, enabling the company to distribute a broad range of pharmaceutical products and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen's federal contract portfolio demonstrates its capability to fulfill diverse medical supply requirements through open competition and its established position as a critical vendor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 12/29/25 |